Carlos Ernesto Lombo Moreno

Carlos Ernesto Lombo Moreno

Auto-generated profile, based on publicly available information

Carlos Ernesto Lombo Moreno

Hospital Universitario San Ignacio

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2022 in International Urogynecology Journal
Verified
Journal Article
Open access
PDF file
CMCarlos Ernesto Lombo Moreno
Carlos Ernesto Lombo Moreno
OVOscar Mauricio Muñoz Velandia
Oscar Mauricio Muñoz Velandia
CSCindy Alejandra Bonilla Sánchez
Cindy Alejandra Bonilla Sánchez
JDJuan Sebastián Montealegre Diaz
Juan Sebastián Montealegre Diaz
JHJavier Ricardo Garzón Herazo
Javier Ricardo Garzón Herazo
Introduction and hypothesis: Complicated urinary tract infection (cUTI) is highly prevalent and costly for health systems. The impact of the indwelling urinary catheter on etiologic agents and clinical outcomes has been poorly studied in Latin America. Methods: Cross-sectional study including patients with cUTI, with positive urine culture, treated at Hospital Universitario San Ignacio, Bogotá (Colombia) between 2017 and 2020. Clinical and microbiologic characteristics, treatments and outcomes are explored, comparing those with and without indwelling urinary catheter. Results: Seven hundred thirty-five patients with non-catheter-associated cUTI (NC-cUTI) and 165 with catheter-associated cUTI (CAUTI) were included. CAUTI group had a higher proportion of recurrent UTI (18% vs 33.3%, p < 0.001), ICU requirement (2.7% vs 8.5%, p < 0.001), longer hospital stay (6 vs 10 days, p < 0.001) and > 30 days unplanned readmission rate (5.8% vs 10.3%, p < 0.001). In the same group, we found a higher frequency of Pseudomonas spp (2.6% vs 9.4%, p < 0.001), Enterococcus spp. (2.4% vs 3.3%, p = 0.016), Serratia marcescens (0.6% vs 3.3%, p < 0.001) and Citrobacter freundii (0.5% vs 5.7%, p < 0.001). It implied a higher number of patients treated with fourth-generation cephalosporins (1.4% vs 4.8%, p = 0.004), ertapenem (32.9% vs 41.8%, p = 0.027) and carbapenems associated with a second antibiotic (1.9% vs 8.5%, p < 0.001). Conclusions: Patients with CAUTI have a higher frequency of resistant germs, require greater use of resources and have worse clinical outcomes than patients who do not require such devices. Measures should be strengthened to minimize its use, in both the hospital and outpatient setting.

1 January 2022 in Clinical and Applied Thrombosis/Hemostasis
Verified
Journal Article
Open access
OMOscar M Muñoz
Oscar M Muñoz
PRPaula Ruiz-Talero
Paula Ruiz-Talero
CHCatalina Hernández-Florez
Catalina Hernández-Florez
CLCarlos Ernesto Lombo-Moreno
Carlos Ernesto Lombo-Moreno
MCMartha Alejandra Casallas-Rivera
Martha Alejandra Casallas-Rivera
CMCarol Anne Mayorga-Hernández
Carol Anne Mayorga-Hernández
Objective: To evaluate the discriminative ability and the calibration of the Pulmonary Embolism Severity Index (PESI) to predict in-hospital mortality in patients with Pulmonary Embolism (PE) secondary to COVID 19 in two hospitals in Bogotá. Methods: External validation study of a prediction model based on a retrospective cohort of patients with PE secondary to COVID-19 treated at Hospital Universitario San Ignacio and Hospital universitario La Samaritana, between March 2020 and August 2021. Calibration of the scale was evaluated using the Hosmer-Lemeshow test and a calibration belt diagram. Discrimination ability was evaluated using a ROC curve. Results: 272 patients were included (median age 61.5 years, male 58.8%). PE was diagnosed in 45.6% of the patients at the time of admission. Of the remaining 54.4%, 95.9% received thromboprophylaxis until the time of diagnosis.17.6% of the patients died. Regarding calibration, the scale systematically underestimates risk in all classes of PESI. For class I, the ratio of observed/expected events was 4.4 vs 0.8%, class II 4.8 vs 1.8%, class III 15.2 vs 4.2%, class IV 14.3 vs 5.9% and class V 46.7 vs 5.8%. The calibration test rejected the adequate calibration hypothesis (p < 0.001). The discriminatory ability was adequate (AUC = 0.7128, 95% CI 0.63-0.79). Conclusions: The PESI scale in patients with PE secondary to COVID 19 underestimates the risk of in-hospital mortality, while maintaining adequate discrimination. It is suggested not to use the PESI scale until it is recalibrated in this context.

22 May 2025 in Therapeutic Advances in Gastroenterology
Verified
Journal Article
Open access
CLCarlos Lombo-Moreno
Carlos Lombo-Moreno
DRDavid La Rotta
David La Rotta
MPManuelita Pardo-Ortiz
Manuelita Pardo-Ortiz
FAFredy Alexander Avila
Fredy Alexander Avila
RCRaul Antonio Cañadas
Raul Antonio Cañadas
AHAlbis Cecilia Hani
Albis Cecilia Hani
Background: In 2023, the diagnostic criteria for gastroesophageal reflux disease (GERD) were updated in the Lyon Consensus 2.0. It is important to investigate the diagnostic accuracy of complementary tests used for GERD diagnosis. Objectives: To determine the diagnostic accuracy of mean nocturnal basal impedance (MNBI) measured by pH-metry in patients with suspected GERD compared to the updated 2023 Lyon Consensus Diagnostic Criteria and to identify the optimal cutoff point for diagnosis. Design: Diagnostic test study based on a retrospective cohort of patients with suspected GERD. Methods: Diagnosis was confirmed using the updated Lyon criteria as the gold standard. We evaluated sensitivity, specificity, and discriminatory ability via area under the receiver operating characteristic curve (AUC-ROC). The best cutoff point was determined using Liu’s method for MNBI, number of reflux episodes, number of acid reflux episodes, DeMeester score, and bolus exposure time. ROC curves were compared using DeLong’s method. Results: A total of 55 patients were included, with 26 diagnosed positive and 29 negative for GERD. MNBI yielded an AUC-ROC of 0.77 (95% confidence interval (CI): 0.64–0.89); at 1590 ohms, sensitivity and specificity were 69.2% and 72.4%, respectively. The DeMeester score demonstrated superior discriminatory ability over MNBI ( p = 0.03), with an AUC-ROC of 0.90 (95% CI: 0.80–1.00), sensitivity of 92%, and specificity of 93% at a cutoff of 15.6. No significant differences in discriminatory ability were observed when comparing MNBI with other complementary tests ( p < 0.05). Conclusion: MNBI and other complementary tests showed suboptimal characteristics for GERD diagnosis. These tests should be interpreted alongside clinical, endoscopic, and pH-metry findings. The DeMeester score seems promising, but further prospective studies are needed to prove its utility.

25 April 2023 in Revista de Gastroenterología de México
Verified
Journal Article
Open access
CLC.E. Lombo-Moreno
C.E. Lombo-Moreno
OMO.M. Muñoz-Velandia
O.M. Muñoz-Velandia
DFD.G. Fernández-Ávila
D.G. Fernández-Ávila
JBJ.E. Barahona-Correa
J.E. Barahona-Correa
VLV. López-Ramírez
V. López-Ramírez
ARA. Rodriguez-Varon
A. Rodriguez-Varon

1 January 2023 in Therapeutic Advances in Gastrointestinal Endoscopy
Verified
Journal Article
Open access
TRTatiana Ramírez-Peña
Tatiana Ramírez-Peña
RVRómulo Darío Vargas-Rubio
Rómulo Darío Vargas-Rubio
CLCarlos Ernesto Lombo
Carlos Ernesto Lombo
LRLuis Miguel Rodríguez-Hortua
Luis Miguel Rodríguez-Hortua
OMOscar Mauricio Muñoz-Velandia
Oscar Mauricio Muñoz-Velandia
Introduction: Dynamic changes in liver function tests have been proposed to correctly reclassify the risk of choledocholithiasis; however, information is scarce and insufficient to recommend its use. Methods: Retrospective cohort of patients undergoing endoscopic retrograde cholangiopancreatography (ERCP) due to moderate and high risk of choledocholithiasis according to the 2019 American Society of Gastrointestinal Endoscopy (ASGE) guidelines. We evaluated whether significant changes in liver function tests (bilirubin, transaminases, or alkaline phosphatase), defined as an increase or a reduction ⩾30 or ⩾50% between two measurements taken with a difference of 24–72 h can correctly reclassify the risk of choledocholithiasis beyond the ASGE guidelines. The net reclassification index (NRI) was calculated for patients with and without choledocholithiasis. Results: Among 1175 patients who underwent ERCP, 170 patients were included in the analysis (59.4% women, median 59.5 years). Among patients without a diagnosis of choledocholithiasis, the number of patients correctly reclassified by transaminases was slightly higher than those incorrectly reclassified (NRI = 0.24 for aspartate amino transaminase and 0.20 for alanine amino transaminase). However, among patients with a diagnosis of choledocholithiasis, it led to incorrect reclassification in a greater number of cases (NRI = −0.21 and −0.14, respectively). The benefits of reclassification were minimal for bilirubin and alkaline phosphatase, or for value changes >50%. A subgroup analysis showed similar findings in patients without a history of cholecystectomy and in those with normal bile duct. Conclusion: Dynamic changes in liver function tests do not improve choledocholithiasis risk classification beyond the 2019 ASGE criteria. New criteria should continue to be sought to optimize risk stratification.

1 January 2024 in Therapeutic Advances in Gastrointestinal Endoscopy
Verified
Journal Article
Open access
ABAndrea C. Buitrago-Tamayo
Andrea C. Buitrago-Tamayo
CLCarlos E. Lombo-Moreno
Carlos E. Lombo-Moreno
VUValentina Ursida
Valentina Ursida
ALAna M. Leguizamo-Naranjo
Ana M. Leguizamo-Naranjo
OMOscar M. Muñoz-Velandia
Oscar M. Muñoz-Velandia
RVRómulo D. Vargas-Rubio
Rómulo D. Vargas-Rubio
Background: Narrow-Band imaging International Colorectal Endoscopic (NICE) could reduce histopathology study requirements in colorectal polyp evaluation. Local and regional studies are required to validate its utility. Objectives: To evaluate concordance between NICE classification and histopathology. Design: Prospective analytic study performed in the Hospital Universitario San Ignacio, Bogotá (Colombia) between 2021 and 2022. Methods: Concordance between NICE I, II and III classification and histopathology [Hyperplastic Polyp (HP), adenoma and deep submucosal invasive cancer (DSIC)] was evaluated using weighted kappa. Diagnostic performance was evaluated for NICE I–II versus NICE III for DSIC versus adenoma/HP. A subgroup analysis was performed for polyps ⩾10 mm and those located in the rectum, sigmoid, and left colon. Results: A total of 238 polyps from 135 patients were evaluated. Median age 67 years (IQR 58.5–74.5), 54.4% males. 23 (17.1%) had ⩾3 polyps. Of polyps, 52.1% were located on rectum, sigmoid and left colon. A total of 182 (76.5%) were <10 mm. NICE and histopathology evidenced a fair-moderate concordance (quadratic weighted kappa 0.36, linear weighted kappa 0.43). NICE classification (NICE I–II versus III) compared to histopathology (DSIC versus adenoma/HP) evidenced a sensitivity of 90.9% and specificity of 99.1%. For DSIC diagnosis specificity was ⩾95% on polyps ⩾10 mm and those left sided located. Conclusion: NICE and histopathology concordance is suboptimal. However, NICE III for DSIC diagnosis evidence good specificity. Therefore, NICE III polyps require a prompt histopathological evaluation and follow-up. Good operative characteristics stand in polyps ⩾10 mm and left sided located. NBI formal training is recommended in gastroenterology units in Latin America.